Agenmestencel-T
Phase 2- Indications
- Gastrointestinal cancer
Company intelligence / Profile preview
Apceth Biopharma
Munich/Ottobrunn/Grosshadern, Bavaria, Germanyrm.minaris.com ↗
- Ownership
- Private
- Employees
- ~120
- Development stage
- Phase 2
01
Overview
Apceth was one of the first companies in Europe to manufacture commercial gene therapies such as Zynteglo™ for bluebird bio. It has also completed Phase I/II trials in engineered cellular therapies for gastrointestinal cancer and somatic cell therapies for peripheral arterial occlusive disease. The company’s main business model was contract development and manufacturing of advanced therapeutic medicinal products (ATMPs) including autologous/allogeneic native or genetically modified cells, with expertise spanning from clinical to commercial scale production.
- Therapeutic areas
- OncologyCardiovascularHematology
- Modalities
- Cell therapyGene therapyStem cell therapyInduced pluripotent stem cell derived therapyCAR-T cell therapyDendritic cell therapyMesenchymal stem cell therapyHematopoietic stem cell therapy
- Industry
- Contract Manufacturing Organization
02
Drug pipeline
1 asset03
Partnerships
bluebird bio – commercial manufacturer in Europe for Zynteglo™ gene therapyIndivumed – biomarker platform development partnership
Beyond the preview
Go deeper on Apceth Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apceth Biopharma.